These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Lopez LR, Simpson DF, Hurley BL, Matsuura E. Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973 [Abstract] [Full Text] [Related]
5. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Matsuura E, Kobayashi K, Tabuchi M, Lopez LR. Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279 [Abstract] [Full Text] [Related]
6. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism. Pengo V, Bison E, Ruffatti A, Iliceto S. Thromb Res; 2008 Nov; 122(4):556-9. PubMed ID: 18328538 [Abstract] [Full Text] [Related]
7. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis. Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E. Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986 [Abstract] [Full Text] [Related]
9. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome. Matsuura E, Kobayashi K, Hurley BL, Lopez LR. Lupus; 2006 Jun; 15(7):478-83. PubMed ID: 16898186 [Abstract] [Full Text] [Related]
10. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. Kobayashi K, Tada K, Itabe H, Ueno T, Liu PH, Tsutsumi A, Kuwana M, Yasuda T, Shoenfeld Y, de Groot PG, Matsuura E. Lupus; 2007 Jun; 16(12):929-38. PubMed ID: 18042586 [Abstract] [Full Text] [Related]
11. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome. Kobayashi K, Lopez LR, Matsuura E. Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014 [Abstract] [Full Text] [Related]
12. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients. Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, Sarzi-Puttini P, Shoenfeld Y, Doria A. Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726 [Abstract] [Full Text] [Related]
13. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease. Rauch J, Salem D, Subang R, Kuwana M, Levine JS. Front Immunol; 2018 Nov; 9():2836. PubMed ID: 30619248 [Abstract] [Full Text] [Related]
18. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation. Adams M. Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304 [Abstract] [Full Text] [Related]
19. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis. Matsuura E, Kobayashi K, Inoue K, Lopez LR, Shoenfeld Y. Lupus; 2005 Apr; 14(9):736-41. PubMed ID: 16218478 [Abstract] [Full Text] [Related]